SIPA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Although the majority of Sipa-1–/–mice develop CML-like myeloproliferative disease, it occurs only after long latent periods over a year, suggesting the requirement of secondary oncogenic hits [20].